KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Other Working Capital Changes (2016 - 2026)

Medtronic's Other Working Capital Changes history spans 13 years, with the latest figure at -$117.0 million for Q1 2026.

  • For Q1 2026, Other Working Capital Changes fell 1.74% year-over-year to -$117.0 million; the TTM value through Jan 2026 reached $927.0 million, up 70.09%, while the annual FY2025 figure was $538.0 million, 55.94% up from the prior year.
  • Other Working Capital Changes for Q1 2026 was -$117.0 million at Medtronic, down from $727.0 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $727.0 million in Q4 2025 and bottomed at -$405.0 million in Q4 2022.
  • The 5-year median for Other Working Capital Changes is -$1.0 million (2024), against an average of $103.6 million.
  • The largest annual shift saw Other Working Capital Changes skyrocketed 1151.43% in 2023 before it crashed 11400.0% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at -$405.0 million in 2022, then skyrocketed by 243.7% to $582.0 million in 2023, then increased by 4.12% to $606.0 million in 2024, then rose by 19.97% to $727.0 million in 2025, then tumbled by 116.09% to -$117.0 million in 2026.
  • Per Business Quant, the three most recent readings for MDT's Other Working Capital Changes are -$117.0 million (Q1 2026), $727.0 million (Q4 2025), and $464.0 million (Q3 2025).